These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15499735)

  • 1. Will higher-than-FFS payment solidify Medicare health plans?
    Med Health; 2004 Oct; 58(36):4-5. PubMed ID: 15499735
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic care improvement in Medicare FFS: cosmetic or transforming?
    Foote SM
    Res Agenda Brief; 2004 May; (13):1-13. PubMed ID: 15228058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare pricing test demonstrates little.
    Gardner J
    Mod Healthc; 2000 Jun; 30(26):78. PubMed ID: 11183528
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicare Advantage's private fee-for-service plans: paying for coordinated care without the coordination.
    Biles B; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2008 Oct; 48():1-12. PubMed ID: 18953765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare advantage hits jackpot with private fee-for-service plans.
    Diamond F
    Manag Care; 2007 May; 16(5):26-8, 31. PubMed ID: 17552335
    [No Abstract]   [Full Text] [Related]  

  • 6. Marketplace. Will M+C be Wennberg's window of Medicare opportunity?
    Med Health; 2001 Mar; 55(11):suppl 1-2. PubMed ID: 11261371
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicare Advantage in the era of health reform: progress in leveling the playing field.
    Biles B; Arnold G; Guterman S
    Issue Brief (Commonw Fund); 2011 Mar; 5():1-14. PubMed ID: 21456325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The continuing cost of privatization: extra payments to Medicare Advantage plans in 2008.
    Biles B; Adrion E; Guterman S
    Issue Brief (Commonw Fund); 2008 Sep; 43():1-15. PubMed ID: 18807648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current state of affairs in managed care: lessons learned and the impact of Medicare advantage.
    Trueman CA
    Caring; 2008 Jan; 27(1):6-7, 1. PubMed ID: 18309805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The medicare drug bill. What's in it for fee-for-service providers?
    Ferman JH
    Healthc Exec; 2003; 18(5):64-5. PubMed ID: 14503081
    [No Abstract]   [Full Text] [Related]  

  • 11. OIG report reveals steady drop in Medicare payment errors.
    Gundling RL
    Healthc Financ Manage; 2001 May; 55(5):68-9. PubMed ID: 11351813
    [No Abstract]   [Full Text] [Related]  

  • 12. Fixing unfair advantages? Providers hope to see more transparency, networks with Medicare private fee-for-service plans in wake of veto override.
    Lubell J
    Mod Healthc; 2008 Jul; 38(29):6-7, 12-3, 1. PubMed ID: 18825797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of privatization: extra payments to Medicare Advantage plans.
    Biles B; Nicholas LH; Cooper BS
    Issue Brief (Commonw Fund); 2004 May; (750):1-12. PubMed ID: 15154416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare Advantage in 2006-2007: what Congress intended?
    Gold M
    Health Aff (Millwood); 2007; 26(4):w445-55. PubMed ID: 17504767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives 2001: a Medicare odyssey to the world of competitive pricing?
    Clemmitt M
    Med Health; 2000 Dec; 54(48):suppl 1-4. PubMed ID: 11139905
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing the scales. MedPAC urges Congress to look at Medicare fee variance.
    Gardner J
    Mod Healthc; 1998 Mar; 28(10):30. PubMed ID: 10177180
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in the Medicare home health care market: the impact of reimbursement policy.
    Choi S; Davitt JK
    Med Care; 2009 Mar; 47(3):302-9. PubMed ID: 19194328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining a future for fee-for-service Medicare.
    Foote SB; Halaas GW
    Health Aff (Millwood); 2006; 25(3):864-8. PubMed ID: 16684754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.